News tagged ‘MultipleMyeloma’ clear
- A new three-drug combination has shown to be "highly effective" in the
treatment of newly diagnosed multiple myeloma patients, say researchers
from Dana-Farber Cancer Institute.
Tags: MultipleMyeloma
- Scientists have unveiled the most comprehensive picture to date of the full genetic blueprint of multiple myeloma. A study of the genomes from 38 cancer samples has yielded insights into the events that lead to this form of blood cancer and could influence the direction of multiple myeloma research.
Tags: MultipleMyeloma, Genetics
The American Society of Clinical Oncology named Ken Anderson, MD, its 2011 David A. Karnofsky Memorial Award and Lecture honoree for his outstanding achievements in cancer research and patient treatment.
Tags: Honors, MultipleMyeloma
Dana-Farber researchers successfully disrupted the function of the gene MYC by tampering with the gene's "on" switch and growth signals in multiple myeloma cells, offering promising strategy for treating myeloma and other cancers driven by the MYC gene.
Tags: BasicResearch, MultipleMyeloma
Scientists have created a "cocktail" combination of four antigenic peptides derived from myeloma cells they believe could provoke the body's defenses to attack multiple myeloma in its early "smoldering" phase and slow or prevent the blood cancer.
Tags: BasicResearch, MultipleMyeloma
A phase 2 clinical trial has shown that pairing bortezomib with an experimental drug, panobinostat, may be a promising treatment for patients with advanced multiple myeloma when the targeted drug bortezomib stops working alone.
Tags: MultipleMyeloma
Dana-Farber researchers report that the molecule P5091 triggers cell death in multiple myeloma cancer cells that have become resistant to Velcade.
Tags: BasicResearch, MultipleMyeloma
Ken Anderson, MD, briefed members of Congress and their legislative staffs on blood cancer care and research, and the importance of protecting and enhancing federal research funding.
Tags: BasicResearch, Grants, MultipleMyeloma